Financial Disclosure Clarification: In an Editorial entitled “Surgical Treatment of Obesity in Adolescence,” published in the February 10, 2010, issue of JAMA (2010;303:559-560), the financial disclosure section should have read: Dr Livingston reported that in 2008 he received an honorarium from Allergan for attending an advisory board meeting. He reported that he has had no direct or indirect financial relationship with Allergan before that single meeting and has had none since.
Financial Disclosure Clarification in: Surgical Treatment of Obesity in Adolescence. JAMA. 2010;303(23):2357. doi:10.1001/jama.2010.794